Paragon Therapeutics Appoints Susanna High As Chief Executive Officer
11/21/24, 2:11 PM
Location
Industry
therapeutics
biotechnology
Position
chief executive officer
Susanna High, MBA, has been appointed as Chief Executive Officer at Paragon Therapeutics, where she will lead the team's efforts to propel the development of transformative therapies and accelerate their potential impact. High brings deep strategic and operational experience in building and leading fast-growing innovative biotech companies.
Company Info
Location
waltham, massachusetts, united states
Additional Info
Paragon Therapeutics, Inc., is a biotechnology company applying cutting-edge science and technology to shape the next generation of novel best-in-class complex biologics for major medical needs. The company is fueling a pipeline of transformative therapies and rapidly advancing them into clinical development.